Towards standardized antifungal susceptibility testing for Sporothrix brasiliensis
Journal of Antimicrobial Chemotherapy · 04.08.2026 · 81 (9)
DOI: 10.1093/jac/dkag286 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 19.08.2026. Verfasst von Bram Spruijtenburg und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology, Radboudumc, Nijmegen, The Netherlands. Hauptthemen laut MEDLINE: Sporothrix, Antifungal Agents. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canisius-Wilhelmina Hospital.
Abstract (Originalsprache)
Sporotrichosis caused by Sporothrix brasiliensis is increasingly reported in South America. Infections in humans are mostly due to zoonotic transmission by cats. For both hosts, itraconazole is the drug of choice despite long treatment duration. Resistance surveillance is warranted, but protocols for antifungal susceptibility testing (AFST) are not always harmonized between laboratories largely due to Sporothrix species being thermally dimorphic and the absence of well-defined consensus methodologies to address how to deal with yeast/mould phases. To standardize susceptibility testing methodology, we propose to modify the current Clinical Laboratory and Standards Institute (CLSI) M38 broth microdilution methodology with S. brasiliensis culture for 7 days at 30°C (rather than 35°C) on potato dextrose agar (PDA), followed by microscopic confirmation of pure mycelial phase. Incubation temperature would also be modified to 30°C for 72 hours. By following this standardized method for at least itraconazole, terbinafine and amphotericin B, S. brasiliensis non-wild-type isolates and correlations with clinical outcomes can be properly investigated. The proposed method is a consensus-oriented interim approach rather than a fully validated standard.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medical Microbiology, Radboudumc, Nijmegen, The Netherlands.
- Radboudumc-CWZ Center of Expertise for Mycology, Nijmegen, The Netherlands.
- Department of Medical Microbiology and Immunology, Canisius-Wilhelmina Hospital (CWZ)/Dicoon, Nijmegen, The Netherlands.
- Post-graduation Program in Health Science, Faculty of Medicine (FAMED), Federal University of Rio Grande (FURG), Rio Grande, Brazil.
- Mycology Laboratory, FAMED-FURG, Rio Grande, Brazil.
- Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
ORCID-Profile: Bram Spruijtenburg, Dallas J Smith, Philippe J Dufresne, Jacques F Meis, Daniel R Matute, Nathan P Wiederhold, Melissa Orzechowski Xavier, Marcus de Melo Teixeira
Förderung
- Canisius-Wilhelmina Hospital
Zitieren
APA
Spruijtenburg, B., Melchior Do Prado, C., Rodrigues Trápaga, M., Smith, D. J., Dufresne, P. J., Meis, J. F., Fernandes, L., Felipe, M. S., Matute, D. R., De Groot, T., Dos Santos, A. R., Cognialli, R. C. R., Wiederhold, N. P., Vicente, V. A., Queiroz-Telles, F., Xavier, M. O., Teixeira, M. M., & Meijer, E. F. J. (2026). Towards standardized antifungal susceptibility testing for Sporothrix brasiliensis. Journal of Antimicrobial Chemotherapy, 81(9). https://doi.org/10.1093/jac/dkag286
Vancouver
Spruijtenburg B, Melchior Do Prado C, Rodrigues Trápaga M, Smith DJ, Dufresne PJ, Meis JF, et al. Towards standardized antifungal susceptibility testing for Sporothrix brasiliensis. Journal of Antimicrobial Chemotherapy. 2026;81(9). doi:10.1093/jac/dkag286
BibTeX
@article{Spruijtenburg2026,
author = {Spruijtenburg, Bram and Melchior Do Prado, Carolina and Rodrigues Trápaga, Mariana and Smith, Dallas J and Dufresne, Philippe J and Meis, Jacques F and Fernandes, Larissa and Felipe, Maria Sueli and Matute, Daniel R and De Groot, Theun and Dos Santos, Amanda Ribeiro and Cognialli, Regielly Caroline Raimundo and Wiederhold, Nathan P and Vicente, Vânia A and Queiroz-Telles, Flavio de and Xavier, Melissa Orzechowski and Teixeira, Marcus de Melo and Meijer, Eelco F J},
title = {Towards standardized antifungal susceptibility testing for Sporothrix brasiliensis},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2026},
volume = {81},
number = {9},
doi = {10.1093/jac/dkag286}
}
EUVIMED